To address the potential metabolic consequences of ATGL loss in cancer, particularly under hypoxic conditions, we investigated ATGL knockout (ATGL-KO) lung cancer cells in in vivo–like in vitro setups. This evidence concerns the gene PNPLA2 and lung carcinoma.